Close

Spark Therapeutics (ONCE) PT Lowered 14% at Chardan Capital Markets as They See Better Value Elsewhere in AAV GT

Go back to Spark Therapeutics (ONCE) PT Lowered 14% at Chardan Capital Markets as They See Better Value Elsewhere in AAV GT